Schnittman S, Talathi R, Wilks M, Hedgire S, Lu M, Fourman L
AIDS. 2024; 38(14):1940-1946.
PMID: 38905489
PMC: 11701974.
DOI: 10.1097/QAD.0000000000003967.
Faua C, Ursenbach A, Fuchs A, Caspar S, Jegou F, Ruch Y
Pathog Immun. 2024; 8(2):92-114.
PMID: 38420260
PMC: 10901154.
DOI: 10.20411/pai.v8i2.638.
Girsch J, Mejia Plazas M, Olivier A, Farah M, Littlefield D, Behl S
Frontiers (Boulder). 2023; 2.
PMID: 36742289
PMC: 9894500.
DOI: 10.3389/fviro.2022.833106.
Pusnik J, Eller M, Tassaneetrithep B, Schultz B, Eller L, Nitayaphan S
J Virol. 2019; 93(14).
PMID: 31043532
PMC: 6600211.
DOI: 10.1128/JVI.00377-19.
Manjati T, Nkambule B, Ipp H
South Afr J HIV Med. 2018; 17(1):445.
PMID: 29568606
PMC: 5843076.
DOI: 10.4102/sajhivmed.v17i1.445.
HIV as a Cause of Immune Activation and Immunosenescence.
Sokoya T, Steel H, Nieuwoudt M, Rossouw T
Mediators Inflamm. 2017; 2017:6825493.
PMID: 29209103
PMC: 5676471.
DOI: 10.1155/2017/6825493.
Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
Gunda D, Kilonzo S, Kamugisha E, Rauya E, Mpondo B
BMC Res Notes. 2017; 10(1):197.
PMID: 28595630
PMC: 5465538.
DOI: 10.1186/s13104-017-2521-0.
Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.
Smith K, Mailliard R, Rinaldo C
For Immunopathol Dis Therap. 2017; 6(1-2):67-77.
PMID: 28344852
PMC: 5363401.
DOI: 10.1615/ForumImmunDisTher.2016014160.
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
Smith K, Mailliard R, Piazza P, Fischer W, Korber B, Fecek R
mBio. 2016; 7(3).
PMID: 27247230
PMC: 4895106.
DOI: 10.1128/mBio.00473-16.
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
Engsig F, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J
Clin Infect Dis. 2014; 58(9):1312-21.
PMID: 24457342
PMC: 6276895.
DOI: 10.1093/cid/ciu038.
How histopathology can contribute to an understanding of defense mechanisms against cryptococci.
Okubo Y, Tochigi N, Wakayama M, Shinozaki M, Nakayama H, Ishiwatari T
Mediators Inflamm. 2013; 2013:465319.
PMID: 24058271
PMC: 3766597.
DOI: 10.1155/2013/465319.
Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.
Gaardbo J, Hartling H, Gerstoft J, Nielsen S
AIDS Res Treat. 2012; 2012:161584.
PMID: 22693657
PMC: 3368166.
DOI: 10.1155/2012/161584.
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Gautam R, Nishimura Y, Lee W, Donau O, Buckler-White A, Shingai M
J Virol. 2012; 86(16):8516-26.
PMID: 22647691
PMC: 3421705.
DOI: 10.1128/JVI.00644-12.
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution.
Zeng M, Paiardini M, Engram J, Beilman G, Chipman J, Schacker T
Blood. 2012; 120(9):1856-67.
PMID: 22613799
PMC: 3433090.
DOI: 10.1182/blood-2012-03-418624.
Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.
Gaardbo J, Hartling H, Gerstoft J, Nielsen S
Clin Dev Immunol. 2012; 2012:670957.
PMID: 22474480
PMC: 3312328.
DOI: 10.1155/2012/670957.
Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection.
Okoye A, Rohankhedkar M, Abana C, Pattenn A, Reyes M, Pexton C
J Exp Med. 2012; 209(4):641-51.
PMID: 22451717
PMC: 3328373.
DOI: 10.1084/jem.20112071.